Cambridge Consultants

Cambridge Consultants, part of Capgemini, and Helius Medical Technologies, Inc (NASDAQ:HSDT), have confirmed that a groundbreaking device they developed for short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (MS) has received marketing authorisation from the US Food and Drug Administration (FDA).

Cambridge Consultants, part of Capgemini, and DSP Concepts, the audio platform powering the world’s best consumer and automotive brands, have announced an agreement that will see Cambridge Consultants offering deep audio product development expertise and technology to the many audio brands in the fast-growing DSP Concepts ecosystem.

Cambridge Consultants and Kytopen announce the initial release of the Flowfect™ Tx System, a breakthrough that will help deliver the full promise of cell therapies to tackle disease.

Eric Wilkinson, Chief Executive Officer, Cambridge Consultants, remembers one of his predecessors, Paul Auton, who has died aged 80.

Cambridge Consultants today unveils Veloci-Vent, a sophisticated emergency ventilator designed and built at the request of the UK Government for use in the treatment of COVID-19.

Massively accelerated image processing supports development of novel treatments for neurological conditions.

Cambridge Consultants wins two prestigious iF DESIGN AWARDS for Aalto, an injection device for rheumatoid arthritis patients, and Alma, a smart cooling case for injectable fertility drugs. 

Breakthrough innovation specialist Cambridge Consultants has partnered with Waymap to create a unique smartphone service that helps visually impaired people to navigate through complex indoor spaces, such as public transport hubs.

In partnership with One Young World, Cambridge Consultants is supporting young people applying technology to address the United Nations Sustainable Development Goals.